147 related articles for article (PubMed ID: 36999743)
1. Appendicitis Associated With Clozapine: Analyses Based on a Spontaneous Reporting System Database in Japan.
Misawa F; Nakajima N; Fujii Y; Takeuchi H
J Clin Psychopharmacol; 2023 May-Jun 01; 43(3):228-232. PubMed ID: 36999743
[TBL] [Abstract][Full Text] [Related]
2. Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics: A Systematic Review and Meta-analysis of Cohort Studies.
Masuda T; Misawa F; Takase M; Kane JM; Correll CU
JAMA Psychiatry; 2019 Oct; 76(10):1052-1062. PubMed ID: 31365048
[TBL] [Abstract][Full Text] [Related]
3. Risk of appendicitis associated with the use of clozapine: A pharmacovigilance study.
Uwai Y; Nabekura T
Asian J Psychiatr; 2022 Nov; 77():103264. PubMed ID: 36150349
[No Abstract] [Full Text] [Related]
4. Analysis of Appendicitis Cases in the Japanese Adverse Drug Event Report (JADER) Database.
Kyotani Y; Zhao J; Nakahira K; Yoshizumi M
Biol Pharm Bull; 2023; 46(5):655-660. PubMed ID: 37121692
[TBL] [Abstract][Full Text] [Related]
5. Analysis of clozapine-induced seizures using the Japanese Adverse Drug Event Report database.
Hatano M; Yamada K; Matsuzaki H; Yokoi R; Saito T; Yamada S
PLoS One; 2023; 18(6):e0287122. PubMed ID: 37307250
[TBL] [Abstract][Full Text] [Related]
6. Relationship between clozapine exposure and the onset of appendicitis in schizophrenia patients: a retrospective cohort study.
Kawakita Y; Takeshima M; Komatsu T; Imanishi A; Fujiwara D; Itoh Y; Mishima K
BMC Psychiatry; 2022 Oct; 22(1):653. PubMed ID: 36271340
[TBL] [Abstract][Full Text] [Related]
7. Neuroleptic malignant syndrome associated with long-acting injectable versus oral second-generation antipsychotics: Analyses based on a spontaneous reporting system database in Japan.
Misawa F; Okumura Y; Takeuchi Y; Fujii Y; Takeuchi H
Schizophr Res; 2021 May; 231():42-46. PubMed ID: 33752105
[TBL] [Abstract][Full Text] [Related]
8. Tardive Dyskinesia and Long-Acting Injectable Antipsychotics: Analyses Based on a Spontaneous Reporting System Database in Japan.
Misawa F; Fujii Y; Takeuchi H
J Clin Psychiatry; 2022 Aug; 83(5):. PubMed ID: 35921512
[No Abstract] [Full Text] [Related]
9. Real-World Data on the Adverse Metabolic Effects of Second-Generation Antipsychotics and Their Potential Determinants in Adult Patients: A Systematic Review of Population-Based Studies.
Bernardo M; Rico-Villademoros F; García-Rizo C; Rojo R; Gómez-Huelgas R
Adv Ther; 2021 May; 38(5):2491-2512. PubMed ID: 33826090
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.
Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224
[TBL] [Abstract][Full Text] [Related]
11. Insomnia and suicide as reported adverse effects of second-generation antipsychotics and mood stabilizers.
Miller BJ; McCall WV
J Clin Sleep Med; 2022 Feb; 18(2):517-522. PubMed ID: 34543183
[TBL] [Abstract][Full Text] [Related]
12. Six Cases of Perforated Appendicitis During Clozapine Treatment.
Steinert T; Jans F
J Clin Psychiatry; 2021 Jun; 82(4):. PubMed ID: 34166590
[No Abstract] [Full Text] [Related]
13. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
14. Clozapine Rechallenge Following Neuroleptic Malignant Syndrome: A Systematic Review.
Lally J; McCaffrey C; OʼMurchu C; Krivoy A; Guerandel A; MacCabe JH; Gaughran F
J Clin Psychopharmacol; 2019; 39(4):372-379. PubMed ID: 31205196
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of adverse reactions among antipsychotic drugs using the Korean Adverse Event Reporting System database from 2010 to 2019.
Oh S; Byeon SJ; Chung SJ
J Psychopharmacol; 2022 Sep; 36(9):1041-1050. PubMed ID: 35695641
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database.
Gianfrancesco FD; Grogg AL; Mahmoud RA; Wang RH; Nasrallah HA
J Clin Psychiatry; 2002 Oct; 63(10):920-30. PubMed ID: 12416602
[TBL] [Abstract][Full Text] [Related]
17. Reintroduction of clozapine after perforation of the large intestine--a case report and review of the literature.
Ikai S; Suzuki T; Uchida H; Mimura M; Fujii Y
Ann Pharmacother; 2013; 47(7-8):e31. PubMed ID: 23757383
[TBL] [Abstract][Full Text] [Related]
18. Clozapine use and risk of diabetes mellitus.
Wang PS; Glynn RJ; Ganz DA; Schneeweiss S; Levin R; Avorn J
J Clin Psychopharmacol; 2002 Jun; 22(3):236-43. PubMed ID: 12006892
[TBL] [Abstract][Full Text] [Related]
19. Diabetic ketoacidosis in patients exposed to antipsychotics: a systematic literature review and analysis of Danish adverse drug event reports.
Polcwiartek C; Vang T; Bruhn CH; Hashemi N; Rosenzweig M; Nielsen J
Psychopharmacology (Berl); 2016 Oct; 233(21-22):3663-3672. PubMed ID: 27592232
[TBL] [Abstract][Full Text] [Related]
20. EPS profiles: the atypical antipsychotics are not all the same.
Weiden PJ
J Psychiatr Pract; 2007 Jan; 13(1):13-24. PubMed ID: 17242588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
